Pharmedium Healthcare Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Pharmedium Healthcare Corporation - overview
Location
Lake Forest, IL, US
Primary Industry
Healthcare
About
Pharmedium Healthcare Corporation specializes in pharmaceutical compounding, providing tailored medication solutions to healthcare providers across various health conditions. The company aims to enhance patient care through its innovative services. Pharmedium Healthcare Corporation concentrates on pharmaceutical compounding services, offering customized medication for healthcare providers. The company, headquartered in Lake Forest, US, was acquired by AmerisourceBergen Corp for USD 2.
575 bn in cash in November 2015. There are no indications of previous business pivots or changes in operations. Pharmedium Healthcare Corporation provides a broad range of pharmaceutical products and services, including prescription medications, over-the-counter drugs, and health-related products across over 20 categories. Their offerings also encompass pharmaceutical compounding to create custom medications that meet individual patient needs, targeting families, seniors, and health-conscious individuals across Canada and the United States.
Pharmedium generates revenue through direct sales of compounded medications and health products, primarily through a B2C transaction model. The company focuses on providing affordable options, including competitive pricing for generics and prescription medications, along with free delivery for bulk purchases. Following the acquisition by AmerisourceBergen Corp in October 2015, Pharmedium Healthcare Corporation is expected to leverage this partnership to enhance its product offerings and expand its geographical reach. The company aims to develop new pharmaceutical solutions and increase penetration in underserved markets by 2025.
Recent funding from the Trade Sale will be utilized to facilitate these growth strategies.
Primary Industry
Healthcare
Sub Industries
Molecular Science, Genetics & Gene Therapy, Hospitals, Pharmaceuticals
Website
www.pharmedium.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Pharmedium Healthcare Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Pharmedium Healthcare Corporation | - | ||||||||
| Secondary Buyout | Completed | Pharmedium Healthcare Corporation | - | ||||||||
| Secondary Buyout | Completed | Pharmedium Healthcare Corporation | - | ||||||||
| Recapitalisation | Completed | Pharmedium Healthcare Corporation | - | ||||||||
| Add-on | Completed | Compass Services | - |
Displaying 1 - 5 of 6
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.